OnePlus 12 Gets ColorOS 17 in India and Temple Wearable Debate Puts Health Tech Claims Under the Lens

India’s technology news has taken two very different turns this week. OnePlus 12 users have started receiving the stable ColorOS 17 update, bringing a new interface, performance changes, and AI-based tools. At the same time, Temple, a small wellness wearable developed by Deepinder Goyal, has triggered a serious debate about health claims, scientific proof, and the responsibility of India-first products.

One story is about making a phone smoother and more useful. The other is a reminder that health technology needs clear limits and stronger evidence.

OnePlus 12 ColorOS 17 stable update begins in India

OnePlus has started rolling out the stable ColorOS 17 update for the OnePlus 12 in India. The software is based on Android 17 and represents a bigger shift for the brand, as OnePlus moves away from the OxygenOS name on supported devices.

The rollout is happening in batches. This means some OnePlus 12 owners may receive it earlier than others. Users can check manually by opening Settings, selecting System and updates, and then tapping Software update.

ColorOS 17 brings visual changes, smoother transitions, and improved handling of background apps. OPPO says its new performance system is designed to keep apps responsive and reduce interruptions when switching between tasks.

For a regular user, the benefit should be felt in simple moments: opening the camera quickly, returning to a recently used app, moving through the notification panel, or switching between messaging, maps, and music during travel.

What users can expect from ColorOS 17

The update also adds more AI-led features, although availability can vary by device, region, and software version.

AI Mind Space is designed to organize saved images, notes, and places into grouped collections. AI Mind Pilot aims to help users find and act on information through spoken or typed requests. There are also AI photo-editing tools that can suggest adjustments to tone, lighting, composition, and retouching.

Other features promoted under ColorOS 17 include AI Face Swap Detection, which is intended to flag potentially manipulated faces in images, and Synthetic Voice Recognition for identifying possible AI-generated voices during supported calls.

These tools should be treated as helpful signals, not perfect answers. For example, a face-swap warning does not prove that an image is fake. Users should still verify suspicious content independently.

Before updating, it is sensible to back up important photos and files, keep at least 50 percent battery, and use a stable Wi-Fi connection. Major updates can take time to settle, especially during the first day or two.

What is the Temple wearable and how does it work

Temple is a small device worn on the side of the head near the temple area using an adhesive patch. It weighs under two grams and is priced at Rs. 85,000 in India.

According to its promotional material, Temple uses an optical sensing method called photoplethysmography, or PPG. This technology shines light into the skin and studies changes in reflected light as blood volume changes with each heartbeat. Smartwatches also use PPG for features such as heart-rate monitoring.

Temple’s BrainFlow feature is presented as a way to track how blood supply to the brain changes in real time. It also offers a proprietary Entropy score, described as an indicator of the body’s effort to regulate itself, including heat management.

Why Temple has attracted criticism

The controversy is not about whether PPG can detect changes in blood volume. It can. The key question is whether a sensor placed on the temple can accurately separate blood flow inside the brain from blood circulation in the scalp and nearby tissue.

Doctors and neurologists quoted by ET and The Indian Express have said that this requires stronger independent evidence. They have also stressed that Temple should not be viewed as a medical device or a replacement for medical assessment.

Temple has described BrainFlow and Entropy as new measures based on emerging science and has said more research will follow. Deepinder Goyal has described it as a fitness and wellness device, not a medical device.

The real need for India-first health products

India needs more homegrown health technology, especially products designed for local needs and priced for wider access. But innovation earns trust only when claims are clear, evidence is transparent, and users understand what a device can and cannot do.

Temple may encourage new research into wearable brain-health signals. For now, consumers should treat it as an expensive wellness product, not a tool for diagnosing disease, predicting stroke, or assessing overall brain health.